Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Affymetrix
33%
Algorithm Comparison
33%
Asporin
100%
Breast Cancer
66%
Breast Carcinogenesis
33%
Breast Epithelial Cells
33%
CDH1
33%
Clinical Follow-up
33%
COL3A1
33%
Cryosection
33%
CTHRC1
66%
Data Pattern
33%
Differentially Expressed
33%
Differentially Expressed Genes
33%
Discoidin Domain Receptor 1 (DDR1)
100%
DVL1
100%
E-cadherin
33%
EMP1
100%
Epithelial-mesenchymal Transition
33%
Frozen Section
33%
Gene Expression Profile
66%
Gene Level
33%
Histological Subtypes
66%
Immunohistochemical Markers
33%
Immunohistochemistry
66%
In Situ Hybridization
33%
In Vitro Transcription
33%
Invasive Breast Carcinoma
100%
Invasive Ductal Carcinoma
33%
Invasive Lobular Carcinoma
33%
KRT17
33%
KRT5
33%
Large Set
66%
Laser Capture Microdissection
100%
Mastectomy Specimen
33%
Metastatic Pattern
33%
Microarray Analysis
100%
Molecular Subclassification
33%
Normal Breast
33%
Optimum Treatment
33%
Pairwise Comparison
33%
Postmenopausal Patients
33%
Protein Level
33%
Rank Product
33%
TGF-β Signaling
33%
Tissue Microarray
66%
Total RNA
33%
Treatment Strategy
33%
Tumor
33%
Tumor Subtype
33%
Biochemistry, Genetics and Molecular Biology
Asporin
100%
Cadherin
33%
Candidate Gene
33%
Carcinogenesis
33%
Differentially Expressed Gene
66%
Frozen Section
33%
Gene Expression
66%
In Situ Hybridization
33%
Laser Microdissection
100%
Mesenchymal-Epithelial Transition
33%
Messenger RNA
33%
RNA
33%
TGF Beta Signaling
33%
Tissue Microarray
66%
Transcription
33%
Triple Helix
66%
Wnt Signaling Pathway
33%
Immunology and Microbiology
Cadherin
33%
CDH1 (Gene)
33%
DDR1
100%
Epithelial Mesenchymal Transition
33%
Frozen Section
33%
Gene Expression
66%
In Situ Hybridization
33%
In Vitro
33%
Laser Microdissection
100%
Ribonucleic Acid
33%
TGF Beta Signaling
33%
Triple Helix
66%
Wnt Signaling
33%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Breast Carcinogenesis
50%
Breast Carcinoma
100%
Lobular Carcinoma
50%
Messenger RNA
50%
Neoplasm
50%
Transforming Growth Factor Beta
50%
Uvomorulin
50%